Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies

Spondylarthropathy Clinical Trial

Official title: Guide-Free Sacroiliac Injection in Spondyloarthropathies

Status Unknown status

Clinical Trial Summary

This study is designed to evaluate the efficacy and safety of guide-free sacroiliac joint (SIJ) injection in refractory sacroiliac pain due to spondyloarthropathies.

Clinical Trial Description

A 20 weeks open-label clinical trial study of 35 patients, with different subtypes of spondyloarthropathies, is conducted In spondyloarthropathy's patients with refractory inflammatory buttock pain (fulfilling inclusion criteria), we performed outpatient guide-free sacroiliac injection of triamcinolone acetonide 40 mg in each joint. Patient (pain, stiffness, sleep disturbance) and Clinician assessments (sacroiliac tenderness, Finger to floor and Schober tests ) are recorded at baseline and every 4 weeks until the end of the study. MRI scoring of sacroiliac joint is recorded according to the Spondyloarthritis Research Consortium of Canada (SPARCC) magnetic resonance imaging (MRI) index for scoring inflammatory lesions in the sacroiliac joints, at baseline and in the end of the study. ;

Related Conditions & MeSH terms

• Spondylarthritis
• Spondylarthropathies
• Spondylarthropathy

• NCT number: NCT00829543
• Study type: Interventional
• Source: Tabriz University
• Status: Unknown status
• Phase: Early Phase 1
• Start date: September 2004
• Completion date: February 2009